Publication | Open Access
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo
63
Citations
40
References
2020
Year
This study calls for caution when clinically implementing CD123 CARTs, encouraging its preferential use as a bridge to allo-HSCT in patients with R/R AML.
| Year | Citations | |
|---|---|---|
Page 1
Page 1